Skip to main content

Global IVD Contract Manufacturing Services Market Forecasts 11% CAGR Driven by Testing by 2030

 The global IVD contract manufacturing services market is set to witness a growth rate of ~11% during the forecast period. Growing preference for point-of-care testing services; government support to scale up production of IVD kits post COVID-19 pandemic; growing incidence of cancer and infectious diseases; and advantages such as cost savings, scalability, technology know-how and risk mitigation offered by IVD contract manufacturers are some of the key factors driving the market growth. 

In-vitro diagnostics (IVD) are tests done on samples such as blood or tissue to detect diseases or other conditions. It is used to monitor a person’s overall health to help cure, treat, or prevent diseases. Cost savings, scalability, technology know-how, and risk mitigation offered by IVD contract manufacturers drive OEMs' decision to outsource to IVD CDMOs.

Download a free sample report now 👉
 https://meditechinsights.com/ivd-contract-manufacturing-services-market/request-sample/

Growing preference for point-of-care (POC) testing services fuels the growth of the IVD contract manufacturing services market

In an endeavor to cut result time and help patients make better-informed decisions about their health, there is considerable demand for IVD testing to move closer to the patient, i.e. point-of-care (POC) diagnostics, whether in the hospital, clinic, physician's office, or home. Manufacturing of specific PoC devices presents manufacturers (OEMs) with a variety of design and manufacturing challenges. For instance, the ability to process high-precision components that involve reagents and fluids are the most relevant capabilities sought by OEMs, which are accomplished by specialized IVD CDMOs.

 “Rising demand for point-of-care IVD devices is a key driver for growth. Recently launched point-of-care IVD instruments and devices are convenient to use and efficient. Manufacturing of specific PoC devices presents manufacturers (OEMs) with a variety of design and manufacturing challenges, which is addressed by IVD CDMOs.” - Director, Leading IVD OEM, United States

Cost savings, scalability, technology know-how and risk mitigation offered by IVD contract manufacturers drives their demand

By partnering with IVD contract manufacturers, OEMs can save costs on labor, automation and can achieve economies of scale at a relatively lower cost. OEMs prefer IVD CDMOs for their scalability, reliability, and cost-effective manufacturing capabilities. OEMs look for IVD CDMOs who have sound technical capabilities that are not part of their core competency. Mitigation of regulatory risks & supply disruption risks is other pivotal factors that urge OEMs to partner with IVD CDMOs. For instance,

  • In January 2025, Akoya Biosciences selected Argonaut Manufacturing Services as its contract manufacturing partner to support the production of in-vitro diagnostic (IVD) products, aiming to accelerate commercialization and expand its IVD offerings

  • In March 2024, Beckman Coulter and Fujirebio collaborated to co-develop patient-friendly, blood-based Alzheimer’s disease tests, leveraging Fujirebio’s IVD expertise and manufacturing capabilities

Growing incidence of cancer and infectious diseases & role of IVDs drives the IVD contract manufacturing services market

IVD plays a critical role in driving clinical decision-making for cancer screening, diagnosis, and treatment. IVD testing provides insights related to a patient’s health status such as risk or predisposition for developing certain cancer; the stage of disease, and the prognosis for progression/remission after therapy.

IVDs are also used to analyze human samples such as blood and saliva. It helps in measuring the concentration of specific substances/analytes, detects the presence or absence of a particular marker or set of markers in response to infection. Clinicians frequently use IVDs to diagnose infectious diseases, guide treatment decisions and even mitigate or prevent future diseases. Continuously rising cases of cancer and infectious diseases are likely to spur the IVD contract manufacturing services market.

Competitive Landscape Analysis

The IVD Contract Manufacturing Services market is marked by the presence of key players such as Jabil Inc., STRATEC, Celestica, Sanmina Corporation, Röchling, KMC Systems, Savyon Diagnostics, Nova Biomedical, Cone Bioproducts, Thermo Fisher Scientific Inc., Cenogenics Corporation, Coris BioConcept, Gerresheimer, and Phillips-Medisize, among others. Some of the key strategies adopted by market players include strategic partnerships and collaborations and geographic expansion.

Download a sample report for in-depth competitive insights
 https://meditechinsights.com/ivd-contract-manufacturing-services-market/request-sample/

 Global IVD Contract Manufacturing Services Market Segmentation

This report by Medi-Tech Insights provides the size of the global IVD contract manufacturing services market at the regional- and country-level from 2023 to 2030. The report further segments the market based on service, technology, and end-user.

Market Size & Forecast (2023-2030), By Service, USD Million

  • Manufacturing Services

  • Assay Development Services

  • Others

Market Size & Forecast (2023-2030), By Technology, USD Million

  • Immunoassays

  • Clinical Chemistry

  • Molecular Diagnostics

  • Hematology

  • Microbiology

  • Coagulation

  • Others

Market Size & Forecast (2023-2030), By End-user, USD Million

  • Medical Device Companies

  • Academic & Research Institutes

  • Others

Market Size & Forecast (2023-2030), By Region, USD Million

  • North America

    • US

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Rest of Europe

  • Asia Pacific

    • China

    • India

    • Japan

    • Rest of Asia Pacific

  • Latin America

  • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
  Associate, Medi-Tech Insights
  +32 498 86 80 79
  info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Digital Pharmaceutical Supply Chain Management Market Sees Increasing Demand with 9% CAGR Until 2030

  The   digital pharmaceutical supply chain management market is projected to grow at a CAGR of 9% from 2025 to 2030.  The growth is driven by the increasing need for enhanced supply chain transparency, demand for temperature-sensitive drug handling, and the shift towards digitization in healthcare operations. However, the high implementation cost and data privacy concerns are notable restraints. The digital pharmaceutical supply chain management includes integration of advanced technologies like AI, blockchain, IoT, and data analytics into the pharmaceutical supply chain. This integration enhances transparency, efficiency, and traceability across sourcing, manufacturing, and distribution processes. The market is vital for ensuring drug safety, mitigating counterfeiting risks, and optimizing logistics. These solutions also aid in regulatory compliance by offering real-time insights and data for reporting. 🔗 Want deeper insights? Download the sample report here: h...
Post a Comment
Read more

Contrast Media APIs Market Evolving Healthcare Needs and Future Business Prospects CAGR 5% by 2030

  The global contrast media APIs market is set to witness a growth rate of 5% in the next 5 years.  Rising volume of diagnostic imaging procedures; technological advancements in imaging modalities; expansion of healthcare infrastructure in emerging markets; rising R&D investments to develop safer and more effective contrast agents, are some of the key factors driving the contrast media APIs market. Contrast media APIs are the primary compounds used in the formulation of contrast agents, which enhance the visibility of internal structures in diagnostic imaging. These APIs play a crucial role in modalities like  computed tomography  (CT),  magnetic resonance imaging  (MRI), and ultrasound by improving the differentiation between tissues, organs, and blood vessels. Typically derived from iodine or gadolinium, they are formulated to ensure solubility, stability, and patient safety during procedures. The manufacturing of contrast media APIs involves stric...
Post a Comment
Read more

Global Healthcare Payer Services Market: AI, Big Data & 8% CAGR Growth Forecast by 2030

  The healthcare payer services market is expected to grow at a CAGR of approximately 8% from 2025 to 2030.  Key drivers include the rising demand for cost-effective healthcare solutions, increased adoption of digital platforms, regulatory changes mandating operational transparency, the surge in healthcare data, and the growing need for fraud prevention mechanisms. However, challenges such as data security concerns and integration complexities act as significant restraints. The healthcare payer services market encompasses a range of administrative, operational, and financial services provided to healthcare payers, including insurance companies, government agencies, and employer groups. These services aim to enhance efficiency, reduce costs, and improve customer satisfaction. Offerings include claims processing, member management, provider management, and analytics for decision-making. The market leverages advanced technologies such as artificial intelligence and cloud compu...
Post a Comment
Read more